Core Insights - Jiukang Bio (300406.SZ) has recently received a Medical Device Registration Certificate from the Beijing Drug Administration, which enhances the company's product categories and strengthens its core competitiveness, positively impacting future development [1] Product Registration Details - The company has obtained registration for several medical testing kits, including: - Urinary Transferrin Determination Kit (Lateral Flow Immunoassay) with registration number 20252400824, valid until September 27, 2030, for quantitative measurement of transferrin in human urine [2] - Fibronectin Determination Kit (Immunoturbidimetric Method) with registration number 20252400825, valid until September 27, 2030, for quantitative measurement of fibronectin in human serum or plasma [2] - Copper Determination Kit (PAESA Colorimetric Method) with registration number 20252400826, valid until September 28, 2030, for quantitative measurement of copper in human serum [2] - Additional Fibronectin Determination Kit (Immunoturbidimetric Method) with registration number 20252400827, valid until September 28, 2030, for quantitative measurement of fibronectin in human serum or plasma [2]

Core Viewpoint - The company, Jiukang Bio, has recently received medical device registration certificates from the Beijing Drug Administration for several diagnostic kits, indicating a significant advancement in its product offerings [1] Group 1: Product Registration - The company has obtained registration for the following products: Urinary Transferrin Assay Kit (Latex Immunoturbidimetric Method) [1] - The company has also received approval for the Fibronectin Assay Kit (Immunoturbidimetric Method) [1] - Additionally, the Copper Assay Kit (PAESA Colorimetric Method) has been registered [1] - Another Fibronectin Assay Kit (Immunoturbidimetric Method) has also been approved [1]